American Journal on Addictions

Papers
(The median citation count of American Journal on Addictions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID‐19 Pandemic in China313
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China94
Editorial: Challenges to Opioid Use Disorders During COVID‐1964
Microinduction of Buprenorphine/Naloxone: A Review of the Literature54
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone52
Initial Information on a Novel Nicotine Product39
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs36
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic33
The Increasing Prevalence of Fentanyl: A Urinalysis‐Based Study Among Individuals With Opioid Use Disorder in New York City24
Building Outreach and Diversity in the Field of Addictions21
Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study21
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets20
Review Article: Anabolic‐Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review18
Development and Feasibility Study of an Addiction‐Focused Phenotyping Assessment Battery18
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China18
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?17
A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder17
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists16
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users16
Substance use, depression, and loneliness among American veterans during the COVID‐19 pandemic15
Physicians’ and Attorneys’ Beliefs and Attitudes Related to the Brain Disease Model of Addiction15
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings14
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths13
The Effects of Cannabis Use: A Test Among Dual Electronic and Combustible Cigarette Users12
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program12
Race, Ethnicity, and Clinical Features of Alcohol Use Disorder Among US Military Veterans: Results From the National Health and Resilience in Veterans Study12
Association of Cannabis Use With Intimate Partner Violence Among Couples With Substance Misuse12
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults12
Case Series: Cariprazine for treatment of methamphetamine use disorder11
Brief Report: Opioid‐Involved Overdose Mortality in United States Veterans11
A Healthcare System‐Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions10
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl10
Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans10
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention9
Alexithymia, Emotion‐Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine‐Exposed Young Adults9
Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness8
Zonisamide as an Adjunctive Treatment to Cognitive Processing Therapy for Veterans With Posttraumatic Stress Disorder and Comorbid Alcohol Use Disorder: A Pilot Study8
Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?8
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex7
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths7
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens6
Associations Between Self‐Reported and Biological Measures of Nicotine Consumption Among Young Adult Nondaily Cigarette Smokers6
Chronic Pain Among Patients With an Opioid Use Disorder6
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder6
Single‐use, co‐use, and polysubstance use of alcohol, tobacco, and cannabis in sexual minority and heterosexual females6
A Comparison of Mental and Behavioral Health Risks Factors Associated With Current Dual Use of Electronic Cigarette and Conventional Tobacco Cigarettes With Exclusive Tobacco Cigarette Use and Nonuse 6
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health6
Systematic review: Rates of psychopathology, substance misuse, and neuropsychological dysfunction among transitional age youth experiencing homelessness6
β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use6
Binge drinking and sexual risk behavior among US sexual and gender minority college students6
Women's and men's experiences in group therapy for substance use disorders: A qualitative analysis5
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016‐20195
Main and Interactive Effects of Nicotine Product Type on Sleep Health Among Dual Combustible and E‐Cigarette Users5
Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β‐Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders5
5
Reduced alcohol use in patients prescribed pioglitazone5
Clinical correlates of drug‐related dreams in opioid use disorder5
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment5
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience5
Cigarette, e‐cigarette, and dual use during the third trimester of pregnancy in a national sample of heterosexual and sexual minority women5
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt5
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder5
Alcohol Use Disorder Among Adults Recovered From Substance Use Disorders4
Legalization of cannabis in Canada—Local media analysis4
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment4
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders4
Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients4
Addiction, Race, and the Structurally Vulnerable4
Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students4
Alcohol Craving and Psychiatric Disorders Among Current Drinkers4
Correlates of optimism among patients in substance use disorder inpatient treatment4
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important4
Congenital syphilis prevention in the context of methamphetamine use and homelessness4
Characterizing autistic traits in treatment‐seeking young adults with substance use disorders4
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms4
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial4
A cross‐sectional study: Nitrous oxide abuse in Parisian medical students4
Nicotine Inhalation and Suicide: Clinical Correlates and Behavioral Mechanisms4
CME Posters (n = 64)4
Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior4
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study4
Systematic Review: Treatment for Addictive Disorder in Transplant Patients4
Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder3
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder3
A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes3
Alcohol use at the intersection of sexual orientation and gender identity in a representative sample of youth in Colorado3
Substance use disorders and treatment in Asian American and Pacific Islander women: A scoping review3
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health3
Case Report: Buprenorphine—A Treatment for Psychological Pain and Suicidal Ideation?3
Buprenorphine Treatment for Opioid Use Disorder in Community‐Based Settings: Outcome Related to Intensity of Services and Urine Drug Test Results3
Gender differences among persons entering medication treatment for opioid use disorder in the community3
3
Excessive Spending in a “Free‐to‐Play” Smartphone Game3
Demographic, Behavioral, and Proximal Risk Factors for Gambling Disorder in the US Military3
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students3
Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs2
Trajectories of prescription opioid and heroin use in adulthood2
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial2
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting2
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students2
Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder2
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain2
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome2
Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion2
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study2
Hazardous Alcohol Use, Impulsivity, and HIV‐Risk Behavior Among HIV‐Positive Russian Patients With a History of Injection Drug Use2
Illegal behaviors as a consequence of gambling disorder2
Association of Mood and Anxiety Disorders and Opioid Prescription Patterns Among Postpartum Women2
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts2
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort2
Trends in substance use disorder diagnoses among Veterans, 2009–20192
Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies2
Poster Presentation Abstracts (CME and Non‐CME)2
2
Brief Report: Rates of Fentanyl Use Among Psychiatric Emergency Room Patients2
Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD2
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis2
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs2
Prescription Drug Monitoring Program: Access in the First Year2
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats2
Opioid use disorder at delivery hospitalization in the United States: 2012–20162
Ketamine use in relation to depressive symptoms among high school seniors2
2
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California1
Opioid use disorder in the active service: Implications for intervention1
PCSS Overview 20201
Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report1
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O1
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study1
Issue Information ‐ Editorial Board1
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit1
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes1
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐191
Call for special issue 20231
1
Sleep disturbance in clients attending a specialist addiction clinic1
Stand against stigma1
1
Symposia, Case Conference, Medical Update, and Case Summaries1
Extended‐release buprenorphine in pregnancy1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting1
Barriers to recovery for medical professionals: Assessing financial support through a survey of Physician Health Programs1
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial1
Age of gambling onset and resultant gambling behavior during young adulthood in the United States1
The association between adverse childhood experiences and treatment response for adults with alcohol and other drug use disorders1
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use1
1
Daily cannabis use may cause cannabis‐induced hyperalgesia1
Racial/ethnic discrimination, ADH1B*3, and coping‐motivated drinking among Black college students1
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States1
AAAP PIPs 20221
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic1
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?1
Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients1
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment1
A call for increased addiction psychiatrist engagement in medical student education1
Opioid Response Network1
Conference Schedule1
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment1
Medication treatment for alcohol use disorder in special populations1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry1
1
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users1
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression1
Averting neonatal abstinence syndrome and treating addiction among rural, opioid‐using young women1
Methadone‐Assisted Opiate Withdrawal and Subsequent Heroin Abstinence: The Importance of Psychological Preparedness1
The Development of Fellowship Training in Addiction Psychiatry1
1
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan1
Brief Report: Predictors of Relapse for Patients With Dextromethorphan Dependence1
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program1
Become a AAAP Member0
Call for review papers 20230
Issue Information ‐ ToC0
Call for review papers 20230
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder0
Renew Your AAAP Membership0
Self assessment ad (002)0
Call for review papers 20220
0
Call for review papers 20230
Opioid use disorder and its association with self‐reported difficulties participating in social activities0
AAAPs Self‐Assessment Exam0
Retrieve your CME from AAAPs Annual Meeting AAAPs Self‐Assessment Examination 20200
AATT AAP on‐demand0
AAAP's Product Portal0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20190
Is your AAAP membership expiring soon?0
REACH0
Treatment Goals and Alcohol Use Outcomes in Veterans With Comorbid Alcohol Dependence and Posttraumatic Stress Disorder0
Issue Information ‐ Editorial Board0
Issue Information0
AAAP on‐demand educational activities0
Call for special issue 20220
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey0
2022: The Year in Review0
0
Call for review papers 20230
Call for special issue 20230
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients0
Issue Information ‐ Editorial Board0
Call for special issue 20220
Exploring the intersection of sexual identity and route of administration in relation to cannabis use among young adult females0
Risk factors for poor progression of addictive internet use across different COVID‐19 periods in China0
Associations between muscle‐building exercise and alcohol use behaviors among adolescent boys: Results from the 2019 Youth Risk Behavior Survey0
AAAP's Annual Meeting and Scientific Symposium0
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths0
Issue Information ‐ Editorial Board0
Issue Information0
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States0
Issue Information ‐ ToC0
Issue Information0
Is your AAAP Membership expiring this month?0
Issue Information ‐ Editorial Board0
Pay for Performance and Treatment Outcome in Agonist Treatment for Opioid Use Disorder0
PCSS 8‐Hour MAT Waiver Course for Medical Students0
Issue Information0
Issue Information ‐ Editorial Board0
Call for Review Papers 20230
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs0
Issue Information ‐ ToC0
Motivational Interviewing PIP0
Stimulants PIP Ad0
Cannabis Use PIP Ad0
2022 Self‐Assessment examination0
Issue Information ‐ ToC0
AAAP Annual meeting ad0
Stand against stigma0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?0
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center0
Submit Your Case Conference Proposal0
Issue Information0
Issue Information0
Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice0
Trends in cocaine use among United States females of reproductive age, 2005–20190
Registration is Open for AAAP's 31st Annual Meeting and Scientific Symposium0
Symposia, Case Conference, and Medical Update0
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder0
0
Issue Information ‐ ToC0
Women in Addiction Psychiatry: How Can Specialty Societies Play a Role in Closing the Gender Gap in Academic Medicine?0
Concurrent Paper Sessions0
Issue Information0
Issue Information0
AJA Stand Against Stigma0
Issue Information0
0.068640947341919